Tender detail
Supply of nintedanib for drug programmes B.87 and B.135
Summary
The Institute of Tuberculosis and Lung Diseases is procuring the medicinal product nintedanib for use under drug programmes B.87 and B.135.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.